leisure time -WSS

leisure time

author：leisure time 2025-08-24 19:11:29 - browse：3

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Palantir health business leans on meeting customers’ needs

WSS

Oak trusses raised to roof of fire

California’s proposed $25 per hour health care minimum wage

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Petition to FDA: Get the lead out of consumer hair dyes

All of Us, NIH's precision medicine initiative, gets a big boost

Live blog: Hearing on CRISPR

hotspot

leisure time

explore

How one medical school became remarkably diverse

Infant mortality in U.S. rose last year for first time in decades: CDC

Affirmative action in medical school literally saved lives

Travis Kelce and the trap of celebrity vaccine endorsements

Medicare details structure of new drug price negotiation program

Living with Fabry disease, a condition that causes chronic pain

Activists slam private health insurers over coverage restrictions

Inari Medical to buy amputation prevention company LimFlow

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why 40% Americans with Parkinson’s don’t see a neurologist

hotspot

After Sarepta trial failure, Duchenne families brace for more debate

Charles Manson follower Leslie Van Houten released from prison after 53 years

California’s proposed $25 per hour health care minimum wage

Petition to FDA: Get the lead out of consumer hair dyes

Coloradans with cystic fibrosis could lose access to Trikafta

Iowa House, Senate pass 6

leisure time

entertainment

entertainment

focus